Antiproliferative Effects of Combined Tamoxifen and Gefitinib in Non-Small Cell Lung Cancer

被引：0
|
作者：
Hua Shen [1 ]
Yuan Yuan [1 ]
Wen Gao [1 ]
Jin Sun [1 ]
Shu, Yong-qian [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Canc Biotherapy Ctr, Nanjing 210029, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2009年 / 63卷 / 05期
关键词：
tamoxifen; gefitinib; NSCLC; EGFR/ER pathway;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
18
引用
收藏
页码：327 / 327
页数：1
相关论文
共 50 条
  • [1] Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects
    Shen, Hua
    Yuan, Yuan
    Sun, Jing
    Gao, Wen
    Shu, Yong-Qian
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (02) : 88 - 92
  • [2] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
  • [3] Gefitinib therapy for non-small cell lung cancer
    Birnbaum A.
    Ready N.
    [J]. Current Treatment Options in Oncology, 2005, 6 (1) : 75 - 81
  • [4] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [5] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [6] ANTICANCER EFFICACY OF CETUXIMAB COMBINED WITH GEFITINIB IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Li, Ziming
    Lu, Shun
    Chen, Zhiwei
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S723 - S723
  • [7] Repurposing of atorvastatin and metformin denotes their individual and combined antiproliferative effects in non-small cell lung cancer
    Salim, Elsayed I.
    Elsebakhy, Safaa
    Hessien, Mohamed
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (03) : 550 - 560
  • [8] Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
    Araki, Takuya
    Yashima, Hideaki
    Shimizu, Kimihiro
    Aomori, Tohru
    Hashita, Tadahiro
    Kaira, Kyoichi
    Nakamura, Tomonori
    Yamamoto, Koujirou
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [9] Gefitinib (Iressa) trials in non-small cell lung cancer
    Johnson, DH
    [J]. LUNG CANCER, 2003, 41 : S23 - S28
  • [10] Gefitinib: an "orphan" drug for non-small cell lung cancer
    Ziogas, Dimitrios C.
    Liontos, Michalis
    Kyriazoglou, Anastasios
    Tsironis, Georgios
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (11): : 899 - 906
12345